Montes Claros, Brazil, Sees Increase in Pharma and Biotech Investments, an Industrial Info Market Brief
Montes Claros, Brazil, Sees Increase in Pharma and Biotech Investments, an Industrial Info Market Brief
Attachment: Montes
Pharmaceutical and biotech companies continue to invest in Montes Claros, located north of Mina Gerais, Brazil. The city has is becoming well known in this segment. As an example, Novo Nordisk is making significant investments in its Montes Claros facilities.
Sanval, a subsidiary of Hipolabo, plans to start operations within two years at its grassroot plant, which represents an investment of more than $18 million.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Latin American Life Science Industry Plans 43 New Plants, an Industrial Inf...
- Novo Nordisk Spends $11 Billion to Make More Weight Loss Drugs
- Big Pharma Reacts to Russia's Move on Ukraine
- Catalent to Spend $100 Million on Italian Drugs Plant
- AstraZeneca Plans to Supply Europe with 400 Million Doses of COVID-19 Vacci...